Feasibility human data together with animal trial outcomes were presented by Dr. Kovarnik at EuroPCR in Paris.
Human feasibility trial proved that clear and stable Doppler signal can be easily obtained and used by the device, when the probe is inserted via a regular central line.
Intravascular ultrasound recordings correlated with clinical findings made by other benchmarking technologies.